Evidence map›Paper›PMID 18842140›Full record

ArticleBMC microbiology2008

Characterization of biofilm matrix, degradation by DNase treatment and evidence of capsule downregulation in Streptococcus pneumoniae clinical isolates.

Luanne Hall-Stoodley, Laura Nistico, Karthik Sambanthamoorthy, Bethany Dice, Duc Nguyen, William J Mershon, Candice Johnson, Fen Ze Hu, Paul Stoodley, Garth D Ehrlich and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed, 244 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Ultrastructural, metabolic and genetic characteristics of determinants facilitating the acquisition of macrolide resistance by Streptococcus pneumoniae.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2024
    Article
  15. Article
  16. Biological puzzles solved by usingJournal of bacteriology · 2024
    Review
  17. Article
  18. Extracellular components in enteroaggregativeFrontiers in cellular and infection microbiology · 2024
    Article
  19. Article
  20. Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Luanne Hall-StoodleyCenter for Genomic Sciences, Allegheny-Singer Research Institute, Pittsburgh, PA 15212, USA. lstoodle@wpahs.org
Laura Nistico
Karthik Sambanthamoorthy
Bethany Dice
Duc Nguyen
William J Mershon
Candice Johnson
Fen Ze Hu
Paul Stoodley
Garth D Ehrlich
J Christopher Post
Allegheny-Singer Research Institute · USDrexel University · USMine Safety Appliances (United States) · US

Funding

THE ROLE OF BIOFILMS IN THE PATHOGENESIS OF OTORRHEAR01DC004173 · NIDCD · ALLEGHENY-SINGER RESEARCH INSTITUTE · PI EHRLICH, GARTH D. · 2000 to 2008
$7.0M
MOLECULAR ANALYSIS OF PATHOGENS IN OTITIS MEDIA BY PCRR01DC002148 · NIDCD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI EHRLICH, GARTH D. · 1994 to 2017
$6.5M
Pneumococcal Biofilms in Otitis MediaR01DC005659 · NIDCD · ALLEGHENY-SINGER RESEARCH INSTITUTE · PI POST, JAMES CHRISTOPHER · 2003 to 2007
$3.1M
NIDCD NIH HHS DC02148NIDCD NIH HHS DC04173NIDCD NIH HHS DC05659NIDCD NIH HHS R01 DC002148NIDCD NIH HHS R01 DC004173NIDCD NIH HHS R01 DC005659
6 · The paper itself

Abstract

backgroundStreptococcus pneumoniae is a common respiratory pathogen and a major causative agent of respiratory infections, including otitis media (OM). Pneumococcal biofilms have been demonstrated on biopsies of the middle ear mucosa in children receiving tympanostomy tubes, supporting the hypothesis that chronic OM may involve biofilm development by pathogenic bacteria as part of the infectious process. To better understand pneumococcal biofilm formation six low-passage encapsulated nasopharyngeal isolates of S. pneumoniae were assessed over a six-eight day period in vitro.

resultsMultiparametric analysis divided the strains into two groups. Those with a high biofilm forming index (BFI) were structurally complex, exhibited greater lectin colocalization and were more resistant to azithromycin. Those with a low BFI developed less extensive biofilms and were more susceptible to azithromycin. dsDNA was present in the S. pneumoniae biofilm matrix in all strains and treatment with DNase I significantly reduced biofilm biomass. Since capsule expression has been hypothesized to be associated with decreased biofilm development, we also examined expression of cpsA, the first gene in the pneumococcal capsule operon. Interestingly, cpsA was downregulated in biofilms in both high and low BFI strains.

conclusionAll pneumococcal strains developed biofilms that exhibited extracellular dsDNA in the biofilm matrix, however strains with a high BFI correlated with greater carbohydrate-associated structural complexity and antibiotic resistance. Furthermore, all strains of S. pneumoniae showed downregulation of the cpsA gene during biofilm growth compared to planktonic culture, regardless of BFI ranking, suggesting downregulation of capsule expression occurs generally during adherent growth.

Indexed as

Anti-Bacterial AgentsAzithromycinBacterial ProteinsBiofilmsChildColony Count, MicrobialDeoxyribonuclease IDNA, BacterialGene Expression ProfilingHumansNasopharynxStreptococcus pneumoniaeAnti-Bacterial AgentsAzithromycinBacterial ProteinsCpsA protein, Streptococcus pneumoniaeDeoxyribonuclease IDNA, Bacterial

Identifiers

PMID18842140
PMCPMC2600794
OpenAlexW2027773277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.